HOFFMANN EITLE Bulletin Trimestriel
Notre bulletin trimestriel vous informe sur les développements en cours en droit de la propriété industrielle ainsi que sur les notifications des offices des brevets. Cliquez sur le bouton ci-dessous pour vous abonner.
Juin 2023
- Patenting Computer-Implemented Inventions in the Mechanical Field is (Almost) Easy
- Patenting Quantum Computing Technologies in Europe and the U.S.
- Louboutin Shoes: Amazon’s Responsibility for Third-Party Offers
- G 2/21: The End of "Plausibility"?
- When Can a German Nullity Action Be Brought During Pending Opposition?
Mars 2023
- Driven by Technology: Patenting AI Before the European Patent Office (Part IV)
- Pre-published Clinical Trials: A Sudden Death for Second Medical Use Claims?
- The EU Clinical Trials Regulation: Implications of the New Transparency Rules on Patenting
- New Administrative Procedures for Invalidity and Revocation of Italian Trademark Registrations
- Opposition to French Patents - A First Assessment
- Late-Filed Inventive Step Submissions - Lessons from T 1042/18
- Abolition of the EPO's "Ten-Day Rule": Simplification and Closing of Gaps
Décembre 2022
- Driven by Technology: Patenting AI Before the European Patent Office (Part III)
- Amendments After Grant and Indirect Infringement - "Broader Protection" Due To Narrower Scope?
- Genome Editing and Morality at the EPO
- "BLESSED": Owning a Trade Mark Is Not Always a Blessing
- History and Entanglement of "Spezi" Trademark; Paulaner's "Spezi" Will Remain on Market for Now
- Plausibility and G2/21
- Preliminary Injunction Proceedings in Germany - New Opportunities for Patentees in Munich?
- The UPC Might Not Be Quite Ready Yet, but You Can Be - the Practitioner's Handbook
Septembre 2022
- Driven by Technology: Patenting AI Before the European Patent Office (Part II)
- Cross-Border Effects From Dutch Courts Without Local Patent Infringement
- The History and Entanglement of the “Spezi” Trademark; What did Riegele and Paulaner Agree Back Then?
- The German Patent Double Protection Prohibition and the UPCA: New Aspects to Consider
- When Are Products "Available to the Public" in the Sense of Art. 54(2) EPC?
- Amendment of the Description before the EPO: An Update
Juin 2022
- Driven by Technology: Patenting AI Before the European Patent Office (Part I)
- Marking Your IP Territory
- Will the EUIPO Lower Its Threshold for Assessing Word Marks on Absolute Grounds?
- Trademarks in the “Metaverse”
- Opting Out but Staying In – The Risk of Ineffective Opt-Outs From the UPC
- The ECJ Rules on Requirement of Validity of Asserted Patent in Provisional Injunction Proceedings
Mars 2022
- The EPO Rules of Procedure of the Boards of Appeal (RPBA)
- Teva v Bayer - UK High Court Decides New Salt Form is Obvious
- LEGO: General Court, Judgment of 24 March 2021 - T 515/19
- Amendment of the Description at the EPO
- Update on Entitlement to Priority under the European Patent Convention
- Changes in Germany and Italy to the National Phase of PCT Applications
- Preparing for the UPC: What to do when
Décembre 2021
- The EPO Rules of Procedure of the Boards of Appeal (RPBA)
- Recent EPO Case Law on Sufficiency: How Much Disclosure is Enough?
- Speculative Examples at the EPO - a Road to Nowhere?
- Three-Dimensional Trademarks in the European Union
- Clarity of Claims at the EPO: Pursuing Broad Claims Without Being Vague
- UPC Update: Austria’s Federal Council Approved Ratification of the PPA
Septembre 2021
- Time to Dust off Strategic Plans for the Unitary Patent?
- Establishing Inventive Step of Medical Use Claims at the EPO
- The European Court of Justice Expands the Registrability of Trademarks
- Additional Remuneration for Employees’ Inventions Made in France
- Biological Sequence Data: XML is the New TXT
- G 1/21 – Oral Proceedings by Videoconference at the EPO
Juin 2021
- Formal Right to Priority under the EPC
- Changes to German Patent Act
- Protectability of a Product both as a Design and as a Patent
- G 1/19 – Computer-Implemented Simulations at the EPO
- Oral Proceedings in Times of the COVID-19 Pandemic – An Update
- Licensing or Selling German IPR can Cause Tax Liability in Germany
